Literature DB >> 15288258

Notch and T cell malignancy.

Patrick A Zweidler-McKay1, Warren S Pear.   

Abstract

Notch signaling is required for normal T cell development. However, Notch expression must be precisely regulated as constitutive Notch signaling leads to T cell lymphomas. Recent evidence has provided insights into potential mechanisms of Notch-mediated lymphomagenesis and its relationship to T cell development. The evidence suggests that Notch likely interacts with several important cellular pathways and can cooperate with other oncogenes during lymphomagenesis. In particular, Notch appears to modulate pre-TCR signaling, inhibit the E2A pathway, and in murine leukemia models, frequently cooperates with Myc, E2A-PBX and dominant negative Ikaros dysregulation. This review will present current knowledge in these areas and explore theories on Notch-mediated T cell lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288258     DOI: 10.1016/j.semcancer.2004.04.012

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  14 in total

Review 1.  The indicative effect of Notch1 expression for the prognosis of T-cell acute lymphocytic leukemia: a systematic review.

Authors:  Jiexian Ma; Min Wu
Journal:  Mol Biol Rep       Date:  2012-02-05       Impact factor: 2.316

2.  Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.

Authors:  P Zhang; Y Yang; R Nolo; P A Zweidler-McKay; D P M Hughes
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

3.  MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.

Authors:  Hiroyuki Kawagoe; Gerard C Grosveld
Journal:  Blood       Date:  2005-08-04       Impact factor: 22.113

4.  The H3K27me3 demethylase dUTX is a suppressor of Notch- and Rb-dependent tumors in Drosophila.

Authors:  Hans-Martin Herz; Laurence D Madden; Zhihong Chen; Clare Bolduc; Eugene Buff; Ravi Gupta; Ramana Davuluri; Ali Shilatifard; Iswar K Hariharan; Andreas Bergmann
Journal:  Mol Cell Biol       Date:  2010-03-08       Impact factor: 4.272

5.  Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.

Authors:  Alexis Dumortier; Robin Jeannet; Peggy Kirstetter; Eva Kleinmann; MacLean Sellars; Nuno R dos Santos; Christelle Thibault; Jochen Barths; Jacques Ghysdael; Jennifer A Punt; Philippe Kastner; Susan Chan
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

6.  Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.

Authors:  Robin Jeannet; Jérôme Mastio; Alejandra Macias-Garcia; Attila Oravecz; Todd Ashworth; Anne-Solen Geimer Le Lay; Bernard Jost; Stéphanie Le Gras; Jacques Ghysdael; Thomas Gridley; Tasuku Honjo; Freddy Radtke; Jon C Aster; Susan Chan; Philippe Kastner
Journal:  Blood       Date:  2010-09-09       Impact factor: 22.113

7.  Tumor stem cells: A new approach for tumor therapy (Review).

Authors:  Min Meng; Xin-Han Zhao; Qian Ning; Lei Hou; Guo-Hong Xin; Li-Feng Liu
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

8.  Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implications for CD4 regulation.

Authors:  Katie L Kathrein; Sheila Chari; Susan Winandy
Journal:  J Biol Chem       Date:  2008-02-20       Impact factor: 5.157

Review 9.  Notch signaling in pediatric malignancies.

Authors:  Patrick A Zweidler-McKay
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

10.  A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.

Authors:  Miaofen G Hu; Amit Deshpande; Miriam Enos; Daqin Mao; Elisabeth A Hinds; Guo-fu Hu; Rui Chang; Zhuyan Guo; Marei Dose; Changchuin Mao; Philip N Tsichlis; Fotini Gounari; Philip W Hinds
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.